Page 446 - ILAE_Lectures_2015

125. MAWHINNEY E, CAMPBELL J, CRAIG J et al (2012) Valproate and the risk for congenital malformations:
Is formulation and dosage regime important? Seizure 21, 215-218.

126. MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AUTHORITY (2015) Medicines related
to valproate: risk of abnormal pregnancy outcomes. https://www.gov.uk/drug-safety-update/medicines-
related-to-valproate-risk-of-abnormal-pregnancy-outcomes#treatment-during-pregnancy

127. HOLMES LB, BALDWIN EJ, SMITH CR et al (2008) Increased frequency of isolated cleft palate in infants
exposed to lamotrigine during pregnancy. Neurology 70, 2152-2158.

128. MORROW J, RUSSELL A, GUTHRIE E et al (2006) Malformation risks of antiepileptic drugs in pregnancy:
a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77, 193-
198.

129. DOLK H, JENTINK J, LOANE M, MORRIS J, JONG-VAN DEN BERG LT On behalf of the EUROCAT
Antiepileptic Drug Working Group (2008) Does lamotrigine use in pregnancy increase orofacial cleft risk
relative to other malformations? Neurology 71, 706-7.

130. MEISCHENGUISER R, D’GIANO CH, FERRARO SM (2004) Oxcarbazepine in pregnancy: clinical
experience in Argentina. Epilepsy Behavior 5, 163-167.

131. MONTOURIS G (2005) Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med
Res Opin 21, 693-702.

132. WILTON LV, SHAKIR S (2002) A post-marketing surveillance study of gabapentin as add-on therapy for
3,100 patients in England. Epilepsia 43, 951-955.

133. LEPPIK I, GRAM L, DEATON R, SOMMERVILLE K (1999) Safety of tiagabine: summary of 53 trials.
Epilepsy Res 33, 235-246.

134. OHMAN I, VITOLS S, LUEF G, SODERFELDT B, TOMSON T et al (2002) Topiramate kinetics during
delivery, lactation and in the neonate: preliminary observations. Epilepsia 43, 1157-1160.

135. HUNT S, RUSSELL A, SMITHSON WH et al (2008) Topiramate in pregnancy: preliminary experience from
the UK Epilepsy and Pregnancy Register. Neurology 22, 272-276.

136. HOLMES LB, SMITH CR, HERNANDEZ-DIAZ S (2008) Pregnancy Registries: Larger sample sizes
essential. Birth Defects Research (Part A) 82, 307.

137. MAWHINNEY E, CRAIG J, MORROW J et al (2013) Levetiracetam in pregnancy: results from the UK and
Ireland Epilepsy and Pregnancy registers. Neurology 80(4), 400-4055.

138. LINDHOUT D, OMTZIGT JGC (1994) Teratogenic effects of antiepileptic drugs: Implications for the
management of epilepsy in women of the child bearing age. Epilepsia 35 (suppl 4), 19-28.

139. PETRERE JA, ANDERSON JA (1994) Developmental toxicity studies in mice, rats and rabbits with the
anticonvulsant gabapentin. Fund Appl Toxicol 23, 585-589.

140. NULMAN I, SCOLNIK D, CHITAYAT D, FARKAS L, KOREN G (1997) Findings in children exposed in
utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J
Med Genet 68, 18-24.

141. RUDD NL, FREEDOM RM (1979) A possible primidone embryopathy. J Pediatr 94, 835-837.
142. JAGER-ROMAN E, DEICHL A et al (1986) Fetal growth, major malformations, and minor anomalies in

infants born to women receiving valproic acid. J Pedriatr 108, 997-1004.
143. ADAB N, TUDUR SC, VINTEN J et al (2003) Common Antiepileptic Drugs in Pregnancy in Women with

Epilepsy (Cochrane review). In: The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd; Issue 3.
144. GAILY E, KANTOLA-SCORSA E, GRANSTROM ML (1988) Intelligence of children of epileptic mothers.

J Pediatr 113, 677-684.
145. SCOLNIK D, NULMAN I, ROVET J et al (1994) Neurodevelopment of children exposed in utero to

phenytoin and carbamazepine monotherapy. JAMA 271, 767-770.
146. ADAB N, JACOBY A, SMITH D, CHADWICK D (2001) Additional educational needs in children born to

mothers with epilepsy. J Neurol Neurosurg Psychiatry 70, 15-21.
147. ADAB N, KINI U, VINTEN J et al (2004) The longer term outcome of children born to mothers with epilepsy.

J Neurol Neurosurg Psychiatry 75, 1575-1583.
148. JONES KLJ, LACRO RV, JOHNSON KA, ADAMS J (1989) Pattern of malformations in the children of

women treated with carbamazepine during pregnancy. N Engl J Med 320, 1661-1666.
149. ORNOY A, COHEN E (1996) Outcome of children born to epileptic mothers treated with carbamazepine

during pregnancy. Arch Dis Child 75, 517-520.
150. DEAN JCS, HAILEY H, MOORE SJ, LLOYD DJ, TURNPENNY PD, LITTLE J (2002) Long term health

and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 39, 251-259.
151. ERIKSSON K, VIINIKAINEN K, MONKKONEN A et al (2005) Children exposed to valproate in utero-

population based evaluation of risks and confounding factors for long-term neurocognitive development.
Epilepsy Res 65, 189-200.
152. THOMAS SV, AJAYKUMAR B, SINDHU L, NAIR MK, GEORGE B, SARMA PS (2008) Motor and
mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 13, 229-236.
153. THOMAS SV, SUKUMARAN S, LUKOSE N, GEORGE A, SARMA PS (2007) Intellectual and language
functions in children in mothers with epilepsy. Epilepsia 48, 2234-40.
154. MCVEARRY KM, GAILLARD WD, VANMETER J, MEADOR KJ (2009) A prospective study of cognitive
fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.
Epilepsy Behav 16, 609-616.
155. BROMLEY RL, MAWER G, LOVE J, et al (2010) Early cognitive development in children born to women
with epilepsy: a prospective report. Epilepsia 51, 2058-2065.
156. NADEBAUM C, ANDERSON VA, VADJA F, REUTENS DC, BARTON S, WOOD AG (2011) Language
skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 76, 719-726.